Vivos Therapeutics, Inc.VVOSNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
1.12
↓ 84% below average
Average (6y)
6.93
Historical baseline
Range
High:27.23
Low:0.51
CAGR
-41.3%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 1.12 | -0.7% |
| 2023 | 1.12 | +121.3% |
| 2022 | 0.51 | -66.2% |
| 2021 | 1.50 | -78.3% |
| 2020 | 6.94 | -31.1% |
| 2019 | 10.08 | -63.0% |
| 2018 | 27.23 | - |